Ameritas Advisory Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $524K | Sell |
7,493
-2,303
| -24% | -$161K | 0.03% | 498 |
|
|
2025
Q1 | $703K | Buy |
9,796
+309
| +3% | +$22.2K | 0.03% | 485 |
|
|
2024
Q4 | $622K | Buy |
9,487
+1,949
| +26% | +$128K | 0.02% | 530 |
|
|
2024
Q3 | $587K | Sell |
7,538
-6,034
| -44% | -$470K | 0.03% | 514 |
|
|
2024
Q2 | $1.06M | Buy |
13,572
+1,672
| +14% | +$130K | 0.04% | 397 |
|
|
2024
Q1 | $860K | Buy |
11,900
+8,275
| +228% | +$598K | 0.04% | 414 |
|
|
2023
Q4 | $226K | Sell |
3,625
-6,826
| -65% | -$426K | 0.01% | 637 |
|
|
2023
Q3 | $691K | Buy |
10,451
+3,710
| +55% | +$245K | 0.03% | 427 |
|
|
2023
Q2 | $437K | Sell |
6,741
-4,098
| -38% | -$266K | 0.06% | 322 |
|
|
2023
Q1 | $779K | Buy |
10,839
+125
| +1% | +$8.98K | 0.04% | 369 |
|
|
2022
Q4 | $726K | Sell |
10,714
-116
| -1% | -$7.87K | 0.03% | 430 |
|
|
2022
Q3 | $594K | Buy |
10,830
+42
| +0.4% | +$2.3K | 0.04% | 395 |
|
|
2022
Q2 | $713K | Sell |
10,788
-1,043
| -9% | -$68.9K | 0.04% | 360 |
|
|
2022
Q1 | $785K | Buy |
11,831
+617
| +6% | +$40.9K | 0.03% | 384 |
|
|
2021
Q4 | $653K | Buy |
+11,214
| New | +$653K | 0.02% | 433 |
|